Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivomixx on Gut Microbiome in Healthy Volunteers
NCT05083572Phase 4Unknown
- Sponsor
- Changi General Hospital
- Start
- Mar 2021
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (4 arms), sponsored by Changi General Hospital. Primary endpoints: Microbiome profile using 16S rRNA sequencing, Inflammatory cytokines using ELISA tests and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT05083572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083572.